Chronic pain patients often arrive at your clinic after trying everything: rest, medication, adjustments, physical therapy, and injections.
Cortisone may provide fast relief. But fast relief does not always mean long-term recovery.
For many chronic tendon and soft-tissue conditions, the better question is not, “How quickly can we turn down the pain?” It is, “How can we help the tissue recover while improving function and reducing recurrence?”
That is where high-intensity shockwave therapy gives chiropractors a powerful, non-invasive option.
JointWave™ delivers concentrated acoustic energy into soft tissue, tendons, and joints. Instead of relying on medication to suppress symptoms, it helps stimulate the body’s natural healing response. Your clinic can use it alongside chiropractic adjustments, mobility work, and rehabilitation to build more complete care plans.
Suppress pain. Stimulate repair. Improve durability.
Cortisone Suppresses Symptoms. Shockwave Stimulates Healing.
Cortisone injections work by reducing inflammation and temporarily calming immune activity around the painful area. That can help a patient move, sleep, or participate in rehabilitation.
However, cortisone does not repair an overloaded tendon, restore damaged soft tissue, or correct the mechanical factors contributing to chronic pain. It primarily changes the patient’s pain and inflammation response.
That distinction matters.
When the pain decreases but the underlying tissue remains compromised, the patient may return to the same activity before the area has recovered. The symptoms can return once the medication wears off. Repeated injections may also create additional concerns, including tissue weakening and cartilage effects.
The Cleveland Clinic explains that cortisone shots typically provide relief for a few weeks to a few months. It also notes that patients with chronic conditions may need additional injections, commonly spaced at least three months apart.
By contrast, JointWave uses acoustic energy to create a controlled mechanical stimulus. This process, known as mechanotransduction, can support local blood flow, cellular signaling, collagen remodeling, and the body’s natural repair processes.
Cortisone turns down the alarm. JointWave helps address the environment behind the alarm.

Better Mechanism. Better Durability. Better Patient Value.
The clinical difference becomes clearer when you compare the intended outcome of each approach.
Cortisone focuses on short-term symptom control. High-intensity shockwave therapy focuses on stimulating a biological response that may continue after the treatment series ends.
That does not mean shockwave produces instant results for every patient. In many cases, improvement builds progressively over several sessions. That gradual response can become a strength: patients often have an opportunity to improve movement and function while the tissue continues adapting.
Research supports a diagnosis-specific approach. Studies of extracorporeal shockwave therapy have reported meaningful improvements in pain and function for conditions such as plantar fasciitis, lateral epicondylitis, calcific shoulder tendinopathy, Achilles tendinopathy, and other chronic soft-tissue problems.
A 2023 randomized study comparing shockwave therapy with corticosteroid injection for greater trochanteric pain syndrome found that both treatments improved patient outcomes at three months, with no significant difference between groups. The study also emphasized that treatment selection should reflect the diagnosis, patient preference, and clinical context. Read the full randomized comparison study.
The broader evidence does not support promising guaranteed tissue regrowth or a universal cure. It does support a more precise claim: shockwave therapy can improve pain and function while stimulating a healing response in chronic soft tissue.
That is a more responsible: and more valuable: conversation to have with your patients.
JointWave vs. Cortisone: Compare the Outcomes
| Clinical or business factor | Cortisone injection | JointWave high-intensity shockwave therapy |
|---|---|---|
| Primary mechanism | Suppresses inflammation and pain signaling | Uses acoustic energy to stimulate mechanotransduction, circulation, and tissue-repair signaling |
| Effect on damaged tissue | Does not repair the underlying tendon or soft tissue | Supports the body’s natural healing and remodeling response |
| Onset of relief | Often faster, sometimes within days | Often builds over a series of treatments |
| Recovery experience | May allow temporary activity with symptoms reduced | Non-invasive sessions can complement mobility work and rehabilitation |
| Recurrence risk | Symptoms may return as the medication wears off; repeated use raises tissue concerns | Designed to address chronic tissue dysfunction and support more durable improvement |
| Long-term risk profile | Repeated injections may affect tendon integrity, cartilage, skin, or blood sugar | Common effects include temporary soreness, discomfort, or bruising; proper screening remains essential |
| Patient experience | Requires a needle and medication | Needle-free, drug-free, and non-surgical |
| Practice model | Commonly tied to medical referral and insurance pathways | Fits a private-pay, cash-based service model |
| Clinic revenue fit | Usually not a chiropractic-controlled revenue stream | Creates a premium, cash-based service that complements chiropractic care |
The table provides a framework: not a substitute for clinical judgment. Patient selection, diagnosis, treatment parameters, contraindications, and rehabilitation all influence outcomes.
Fewer Injections. More Options. Stronger Care Plans.
Your patients want alternatives to repeated medication, injections, and surgery. Your clinic needs a way to deliver those alternatives efficiently.
JointWave can help you build a broader non-invasive pain therapy offering for chronic conditions that have not responded to traditional care alone.
Common areas of clinical interest may include:
- ✅ Plantar fasciitis and chronic heel pain
- ✅ Tennis elbow and other tendinopathies
- ✅ Achilles and patellar tendon complaints
- ✅ Shoulder stiffness and tendinopathy
- ✅ Hip and gluteal soft-tissue pain
- ✅ Knee pain and joint stiffness
- ✅ Trigger points and selected chronic muscular pain patterns
JointWave does not replace a careful examination or appropriate referral. Instead, it gives you another tool for patients who may benefit from a structured, non-invasive approach.
You can integrate treatment with adjustments and rehabilitation using a progressive plan:
- Evaluate the patient and identify the likely pain generator.
- Apply high-intensity shockwave therapy to the target tissue using appropriate parameters.
- Reinforce the result with movement, mobility, strengthening, and chiropractic care.
For additional implementation ideas, review our guide to integrating high-intensity shockwave therapy with traditional adjustments.
Premium Technology. Durable Equipment. Better ROI.
Not every shockwave system delivers the same depth, energy, consistency, or long-term value.
JointWave treatment heads are technologically superior and engineered for demanding clinical environments. They are built to outlast major competitors, helping your practice reduce downtime, protect treatment consistency, and improve long-term return on investment.

That durability matters because your equipment must support more than occasional use. It must perform reliably as your patient volume grows.
JointWave also helps reduce the friction that causes many practices to underuse new technology. We provide:
- ✅ White-glove installation
- ✅ Staff training and treatment guidance
- ✅ Patient-facing marketing materials
- ✅ Support with positioning and pricing
- ✅ Strategies for integrating treatment into existing care plans
- ✅ A private-pay service model that can diversify clinic revenue
A treatment device only creates value when your team uses it confidently and your patients understand why it matters. Our JointWave ROI guide explains how clinics can connect better outcomes with a stronger cash-based offering.
Build Trust. Improve Outcomes. Grow Revenue.
When patients see that your clinic offers more than temporary symptom management, your position changes.
You become the practice patients visit when traditional approaches have not delivered enough progress. You can provide a non-invasive option for chronic pain while maintaining the hands-on, relationship-centered care that defines chiropractic practice.
That creates three benefits:
- Better patient conversations: You can explain the difference between suppressing symptoms and supporting tissue recovery.
- Better clinical flexibility: You can combine JointWave with adjustments, exercise, and rehabilitation.
- Better business performance: You can add a premium cash-based service without relying entirely on insurance reimbursement.
As Mass General Brigham notes, injections should not stand alone. Rehabilitation and active patient participation remain essential. The same principle applies to shockwave therapy: the best results come from a complete care plan.
Try JointWave Risk-Free for 30 Days
You do not need to make a long-term decision based on a sales presentation.
JointWave offers a 30-day risk-free, in-office trial with no obligation. Bring the system into your practice, train your team, identify appropriate patients, and evaluate how high-intensity shockwave therapy fits your clinical and business model.
You can experience:
- ✅ The patient response to a needle-free therapy
- ✅ The workflow impact on your team
- ✅ The treatment head’s performance in daily use
- ✅ The potential for a new cash-based revenue stream
- ✅ The value of installation, training, and marketing support
Do not keep sending chronic pain patients toward temporary solutions when your clinic can offer a more complete path forward.
Visit jointwavetrial.com and start your 30-day risk-free JointWave trial today.
Clinical note: High-intensity shockwave therapy is not appropriate for every patient or diagnosis. Screen for contraindications, follow applicable regulations and manufacturer guidance, and use sound clinical judgment when determining treatment plans.